TICKDELTA
Sign in
Screener / SEC EDGAR /CIK 0001393052 /10-K filed Mar 20, 2026, compared with Mar 24, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
CRLVEEVALGNPODDWSTRVTY
NYSE Health care · Software

Veeva Systems VEEV

VEEV quote by TradingView

Veeva is the leading provider of industry cloud solutions for the global life sciences industry. 10-K, Item 1

Employees
7,928
Headquarters
Pleasanton, CA
Next results
around Mar 3, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2026

Revenue of $3.2B through the costs to a net profit of $908.9M · income statement of the 10-K

29% operating margin
Revenue to Gross profit: $2.4BRevenue to Cost of revenue: $782.0MGross profit to Operating profit: $916.4MGross profit to Operating expenses: $1.5BOperating profit to Net profit: $630.8MOperating profit to Tax: $285.6MOther income to Net profit: $278.1MOperating expenses to R&D: $767.4MOperating expenses to Sales, admin & other: $729.5M Revenue: $3.2B REVENUE $3.2B +16% Y/Y Gross profit: $2.4B · 76% margin GROSS PROFIT $2.4B 76% margin · +18% Y/Y Cost of revenue: $782.0M · 24% of revenue COST OF REVENUE $782.0M 24% of revenue Operating profit: $916.4M · 29% margin OPERATING PROFIT $916.4M 29% margin · +33% Y/Y Other income: $278.1M · 9% of revenue OTHER INCOME $278.1M 9% of revenue Operating expenses: $1.5B · 47% of revenue OPERATING EXPENSES $1.5B 47% of revenue Net profit: $908.9M · 28% margin NET PROFIT $908.9M 28% margin · +27% Y/Y Tax: $285.6M · 9% of revenue TAX $285.6M 9% of revenue R&D: $767.4M · 24% of revenue R&D $767.4M 24% of revenue Sales, admin & other: $729.5M · 23% of revenue SALES, ADMIN & OTHER $729.5M 23% of revenue
Gross profit $2.4B 76% margin · +18% Y/Y
Operating profit $916.4M 29% margin · +33% Y/Y
Net profit $908.9M 28% margin · +27% Y/Y
The full income statement, year by year

VEEV among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 16.3%, above 90% of 59 peers (their median 7.1%) REVENUE GROWTH 16.3% · above 90% Gross margin: 75.0%, above 86% of 50 peers (their median 64.2%) GROSS MARGIN 75.0% · above 86% Operating margin: 29.9%, above 90% of 50 peers (their median 13.4%) OPERATING MARGIN 29.9% · above 90% Net margin: 29.3%, above 97% of 59 peers (their median 9.5%) NET MARGIN 29.3% · above 97% Return on capital: 9.4%, above 59% of 41 peers (their median 9.0%) RETURN ON CAPITAL 9.4% · above 59%
VEEV Peer median Below the median

What changed

19 new risk paragraphs. 10-K filed Mar 20, 2026 against Mar 24, 2025.

Risk factors
19 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Accounting checks
10 other checks clear
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
1 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

10 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 10 checks found nothing to note

  • Receivables +23.9% vs revenue +16.3% (+7.6 pts)
  • Cash from operations $1.4B vs net income $908.9M (FY ending Jan 31, 2026)
  • Same auditor in both 10-Ks: KPMG LLP
7 more checks with nothing to note
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Evaluation of the sufficiency of audit evidence over revenue
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

19 paragraphs in Risk Factors that were not in the 10-K filed Mar 24, 2025. Quoted as filed.

All 19 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Mar 24, 2025 10-K, ITEM 1A
    We process personal data on behalf of our customers, who use our solutions to manage personal data of their employees, healthcare professionals, patients, and related individuals. We also process personal data as part of the Veeva Data Cloud offerings, which provide our customers with professionally relevant data related to healthcare…
  2. Item 1A · new paragraph · not in the 10-K filed Mar 24, 2025 10-K, ITEM 1A
    In 2025, the U.S. Department of Justice issued a final rule that places limitations, and in some cases prohibitions, on certain transfers of and access to certain personal data of U.S. persons by persons and entities located in China (and other designated countries) or controlled by a person or entity located in China (and other…
  3. Item 1A · new paragraph · not in the 10-K filed Mar 24, 2025 10-K, ITEM 1A
    As we expand our data product offerings into new jurisdictions, we are required to assess, monitor, and comply with additional laws and regulations related to our collection and processing of data, which may include new registration, consent, and notification obligations. In addition to our own processing of personal data, our customers…
  4. Item 1A · new paragraph · not in the 10-K filed Mar 24, 2025 10-K, ITEM 1A
    Salesforce also has the right, in certain circumstances, to terminate the wind-down period early, including in the event of a material breach of the agreement by us, or if Salesforce is subjected to third-party intellectual property infringement claims based on our solutions (except to the extent based on the Salesforce platform) or our…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

From the same starting line, FY2017 to FY2026

Revenue, net income and free cash flow, each set to 100 in FY2017. What happened, from the 10-Ks. Not a forecast.

FY2017 = 100
500 1000 100 Revenue: $550.5M in FY2017, $3.2B in FY2026 REVENUE $3.2B · 5.8x Net income: $77.6M in FY2017, $908.9M in FY2026 NET INCOME $908.9M · 11.7x FY2017 = 100FY2022FY2026
Revenue 5.8x $550.5M to $3.2B
Net income 11.7x $77.6M to $908.9M

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2023FY2024FY2025FY2026
Revenue$2.2B$2.4B$2.7B$3.2B
Net income$487.7M$525.7M$714.1M$908.9M
Operating cash flow$780.5M$911.3M$1.1B$1.4B

Revenue, FY2017 to FY2026

Ten fiscal years, each from its own 10-K · XBRL · USD

$3.2B ▲ 16.3% in FY2026

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Every number, year by year

Recent filings

1 filing in the last 30 days · SEC EDGAR

All filings

About the company

Veeva Systems, Pleasanton, CA · from the 10-K filed Mar 20, 2026

Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions - from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations.

Headquarters
Pleasanton, CA
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
January 31
Last results
Nov 6, 2026
Incorporated in
DE

Employees, at the top of the page: "As of January 31, 2026, we had 7,928 employees worldwide, up by 637 from the previous year" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Mar 20, 2026 (open at SEC), compared with the 10-K filed Mar 24, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VEEV/export.csv") into a cell.